EMEA-000463-PIP02-10

Key facts

Invented name
Glivec
Active substance
Imatinib (mesilate)
Therapeutic area
Cardiovascular diseases
Decision number
P/85/2011
PIP number
EMEA-000463-PIP02-10
Pharmaceutical form(s)
  • Film-coated tablet
  • Capsule, hard
  • Age appropriate formulation
Condition(s) / indication(s)
Treatment of pulmonary arterial hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited
paediatric.enquiries@novartis.com
Switzerland
Phone: +41 61 324 1111
Fax: +41 61 324 8001
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating